|
Real-time Estimate
Tradegate
13:22:15 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 60.18 EUR | +0.54% |
|
+3.88% | -5.12% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LABORATORIOS FARMACEUTICOS ROVI, S.A. | Other Pharmaceuticals | +0.50% | +3.88% | -5.12% | +3.34% | -7.31% | 3.57B |  |  | |
- Stock Market
- Stocks
- ROVI Stock
- Charts Laboratorios Farmaceuticos Rovi, S.A.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
